Category: Manufacturing
Magazine: Digital twins become the new battleground for CDMOs
Pharmaceutical Technology
In this issue: CDMOs use of digital twins to realise a strategic advantage, Physical AI’s rise in pharma manufacturing, and more.
Whitepaper: CDMOs at a Crossroads
BioSpace
In this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers.
Lilly investing billions to prepare for overseas oral GLP-1 launches
BioSpace
With many overseas patients preferring orals to injectables, Eli Lilly has filed for approval of orforglipron in more than 40 countries and is building manufacturing capacity to support the obesity dr
USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns
BioSpace
Almost half of the top 100 medicines vulnerable to supply disruptions in the U.S.
Innovent’s CDMO gets green light to make biologics at large Chinese plant
BioSpace
The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.
In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe
Pharmaceutical Technology
In 2025, biopharma companies increasingly invested in Europe-based contract manufacturing for FDA-approved drugs compared to US-based providers.
BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot
BioSpace
BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology continues to face headwinds in the U.S.
Novo Sheds 400 at Embattled Manufacturing Site
BioSpace
Follow along as BioSpace tracks job cuts and restructuring initiatives.